C07D 295/155
With the ring nitrogen atoms and the carbon atoms with three bonds
Official title: with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
C07D295/155 (With the ring nitrogen atoms and the carbon atoms with three bonds) appears on 878 US grants and 878 published applications in this corpus.
Search patents in C07D- Granted patents
- 878
- Published applications
- 878
- Assignees
- 497
- Inventors
- 3,249
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 8 | 0 |
| 1978 | 7 | 0 |
| 1979 | 4 | 0 |
| 1980 | 8 | 0 |
| 1981 | 9 | 0 |
| 1982 | 6 | 0 |
| 1983 | 9 | 0 |
| 1984 | 19 | 0 |
| 1985 | 11 | 0 |
| 1986 | 13 | 0 |
| 1987 | 12 | 0 |
| 1988 | 5 | 0 |
| 1989 | 5 | 0 |
| 1990 | 6 | 0 |
| 1991 | 5 | 0 |
| 1992 | 11 | 0 |
| 1993 | 10 | 0 |
| 1994 | 13 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 10 | 0 |
| 1998 | 15 | 0 |
| 1999 | 16 | 0 |
| 2000 | 12 | 0 |
| 2001 | 27 | 6 |
| 2002 | 21 | 26 |
| 2003 | 25 | 37 |
| 2004 | 24 | 58 |
| 2005 | 16 | 47 |
| 2006 | 20 | 48 |
| 2007 | 25 | 50 |
| 2008 | 23 | 46 |
| 2009 | 35 | 53 |
| 2010 | 35 | 47 |
| 2011 | 28 | 35 |
| 2012 | 38 | 43 |
| 2013 | 42 | 38 |
| 2014 | 37 | 53 |
| 2015 | 49 | 36 |
| 2016 | 28 | 44 |
| 2017 | 42 | 29 |
| 2018 | 22 | 21 |
| 2019 | 22 | 22 |
| 2020 | 13 | 24 |
| 2021 | 18 | 18 |
| 2022 | 12 | 25 |
| 2023 | 13 | 18 |
| 2024 | 15 | 18 |
| 2025 | 11 | 23 |
| 2026 | 7 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Phosphate compounds for detecting neurological disorders18 Aug 2026US 12,708,676 B2Amydis, Inc.
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications9 Jun 2026US 12,649,712 B2NucMito Pharmaceuticals Co. Ltd.
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Process for the preparation of sulfamoylbenzoic acid derivatives1 Oct 2026US 2026/0297022 A1Iama Therapeutics S.R.L.
- Novel mitofusin inhibitors17 Sep 2026US 2026/0274810 A1Albert Einstein College of Medicine
- Amyloid targeting agents30 Jul 2026US 2026/0217667 A1Amydis, Inc.
- Novel inhibitors of dna damage responses for cancer therapy23 Jul 2026US 2026/0209193 A1The Regents of the University of California
Most cited
By later US patents
- Apoptosis promoters226US 7,390,799 B2Abbott Laboratories · 2008
- Deacetylase inhibitors168US 6,552,065 B2Novartis AG · 2003
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983